Glenmark Q3 net dips 47 pc at Rs 114.77 cr
Glenmark Pharmaceuticals today reported a 46.92 per cent dip in its consolidated net profit at Rs 114.77 crore for the quarter ended December 31, 2014 mainly due to forex losses and increased expenses.
Feb 12, 2015, 19:23 PM IST